Wednesday, September 10, 2014 6:51:31 PM
CEO said as more and more research comes out on CBD and CBDV, he wouldn't be surprised if he is talking at a conference in a year or 2 about the ANTI-CANCER ANTI- INFLAMMATORY properties CBD and CBDV have.. The CEO gave investors a HUGE HINT from the 9/8 conference ..GWPH hold minimum to 2016..price target $350
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM